Low Back Pain — Wearable Devices to Monitor Efficacy of Epidural Steroid Injection in Patients With Low Back Pain
Citation(s)
Fritz JM, Irrgang JJ A comparison of a modified Oswestry Low Back Pain Disability Questionnaire and the Quebec Back Pain Disability Scale. Phys Ther. 2001 Feb;81(2):776-88. Erratum in: Phys Ther. 2008 Jan;88(1):138-9.
Grotle M, Brox JI, Vøllestad NK Functional status and disability questionnaires: what do they assess? A systematic review of back-specific outcome questionnaires. Spine (Phila Pa 1976). 2005 Jan 1;30(1):130-40. Review.
Knowles LM, Skeath P, Jia M, Najafi B, Thayer J, Sternberg EM New and Future Directions in Integrative Medicine Research Methods with a Focus on Aging Populations: A Review. Gerontology. 2016;62(4):467-76. doi: 10.1159/000441494. Epub 2015 Nov 7. Review.
Luo X, Pietrobon R, Sun SX, Liu GG, Hey L Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine (Phila Pa 1976). 2004 Jan 1;29(1):79-86.
Using Wearable Monitoring Devices for Assessing Efficacy of Epidural Steroid Injection in Patients With Low Back Pain
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.